Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Jacobi

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2021
Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3Jennifer Faber, Tamara Schaprian, Koyak Berkan, et al.
Cerebellum (London, England)|June 25, 2011
Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findingsHeike Jacobi, Till-Karsten Hauser, Paola Giunti, et al.
Movement Disorders Clinical Practice|October 27, 2018
Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease ProgressionAlhassane Diallo, Heike Jacobi, Tanja Schmitz-Hübsch, et al.
The Lancet. Neurology|September 18, 2015
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2019
Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar AtaxiaAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Journal of Medical Genetics|May 1, 2014
Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6Sophie Tezenas du Montcel, Alexandra Durr, Maria Rakowicz, et al.
Journal of Neurology|July 1, 2018
Long-term evolution of patient-reported outcome measures in spinocerebellar ataxiasHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Annals of Neurology|November 14, 2023
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Jennifer Faber, Moritz Berger, Carlo Wilke, et al.
Ebiomedicine|December 24, 2025
Brain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichmentHannah Baumeister, Philipp Wegner, Mónica Ferreira, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Stage-dependent biomarker changes in spinocerebellar ataxia type 3Jennifer Faber, Moritz Berger, Wilke Carlo, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2021
Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3Jennifer Faber, Tamara Schaprian, Koyak Berkan, et al.
Cerebellum (London, England)|June 25, 2011
Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findingsHeike Jacobi, Till-Karsten Hauser, Paola Giunti, et al.
Movement Disorders Clinical Practice|October 27, 2018
Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease ProgressionAlhassane Diallo, Heike Jacobi, Tanja Schmitz-Hübsch, et al.
The Lancet. Neurology|September 18, 2015
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2019
Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar AtaxiaAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Journal of Medical Genetics|May 1, 2014
Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6Sophie Tezenas du Montcel, Alexandra Durr, Maria Rakowicz, et al.
Journal of Neurology|July 1, 2018
Long-term evolution of patient-reported outcome measures in spinocerebellar ataxiasHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Annals of Neurology|November 14, 2023
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Jennifer Faber, Moritz Berger, Carlo Wilke, et al.
Ebiomedicine|December 24, 2025
Brain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichmentHannah Baumeister, Philipp Wegner, Mónica Ferreira, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Stage-dependent biomarker changes in spinocerebellar ataxia type 3Jennifer Faber, Moritz Berger, Wilke Carlo, et al.
Pageof 7